Information Technology Reference
In-Depth Information
3 compound metformin hydrochloride using in silico modeling', J. Pharm.
Sci. , 101(5): 1773-82.
Dannenfelser, R.M., He, H., Joshi, Y. , Bateman, S., and Serajuddin, A.T. (2004)
'Development of clinical dosage forms for a poorly water soluble drug I:
application of polyethylene glycol-polysorbate 80 solid dispersion carrier
system', J. Pharm. Sci. , 93(5): 1165-75.
Davis, T.M., Daly, F. , Walsh, J.P., Ilett, K.F., Beilby, J.P., et al . ( 2000) ' Pharmacokinetics
and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines
with type 2 diabetes', Br. J. Clin. Pharmacol. , 49(3): 223-30.
De Buck, S.S., Sinha, V.K., Fenu, L.A., Nijsen, M.J., Mackie, C.E., and Gilissen,
R.A. (2007a) 'Prediction of human pharmacokinetics using physiologically
based modeling: a retrospective analysis of 26 clinically tested drugs', Drug
Metab. Dispos. , 35(10): 1766-80.
De Buck, S.S., Sinha, V.K., Fenu, L.A., Gilissen, R.A., Mackie, C.E., and Nijsen,
M.J. (2007b) 'The prediction of drug metabolism, tissue distribution, and
bioavailability of 50 structurally diverse compounds in rat using mechanism-
based absorption, distribution, and metabolism prediction tools', Drug
Metab. Dispos. , 35(4): 649-59.
Dellis, D., Giaginis, C., and Tsantili-Kakoulidou, A. (2007) 'Physicochemical
profi le of nimesulide: exploring the interplay of lipophilicity, solubility and
ionization', J. Pharm. Biomed. Anal. , 44(1): 57-62.
Delrat, P. , Paraire, M., and Jochemsen, R. (2002) 'Complete bioavailability and
lack of food - effect on pharmacokinetics of gliclazide 30 mg modifi ed release
in healthy volunteers', Biopharm. Drug Dispos. , 23(4): 151-7.
European Medicines Agency Committee for Medicinal Products for Human Use.
(2010) Guideline on the Investigation of Bioequivalence. London: European
Medicines Agency. Available at: http://www.ema.europa.eu/docs/en_GB/
document_library/Scientifi c_guideline/2010/01/WC500070039.pdf. (accessed
3 June 2012).
Galia, E., Nicolaides, E., Hörter, D., Löbenberg, R., Reppas, C., and Dressman,
J.B. (1998) 'Evaluation of various dissolution media for predicting in vivo
performance of class I and II drugs', Pharm. Res. , 15(5): 698-705.
GastroPlus™ Available at: http://www.simulations-plus.com/ (accessed
3 June 2012).
Głowka, F.K., Hermann, T. W. , and Zabel, M. (1998) 'Bioavailability of gliclazide
from some formulation tablets', Int. J. Pharm. , 172(1): 71-7.
Gonda, I. and Gipps, E. (1990) 'Model of disposition of drugs administered into
the human nasal cavity', Pharm. Res. , 7(1): 69-75.
Grass, G.M. (1997) 'Simulation models to predict oral drug absorption from in
vitro data', Adv. Drug Deliv. Rev. , 23(1-3): 199-219.
Grass, G.M. and Lee, V.H. (1993) 'A model to predict aqueous humor and
plasma pharmacokinetics of ocularly applied drugs', Invest. Ophthalmol. Vis.
Sci. , 34(7): 2251-9.
Grass, G.M. and Sinko, P.J. (2002) 'Physiologically-based pharmacokinetic
simulation modeling', Adv. Drug Deliv. Rev. , 54(3): 433-51.
Grbic, S., Parojcic, J., Djuric Z., and Ibric, S. (2009) 'Mathematical modeling of
pH-surfactant-mediated solubilization of nimesulide', Drug Dev. Ind. Pharm. ,
35(7): 852-6.
￿
￿
￿
 
Search WWH ::




Custom Search